Records View

Prospective study for comparison of detetion rate for AOV between dual capsule endoscopy and single capsuel endoscopy

Status Approved

  • First Submitted Date

    2017/07/25

  • Registered Date

    2017/11/17

  • Last Updated Date

    2017/11/01

CRIS Required

WHO ICTRP (International Clinical Trial Registry Platform) Required

  • 1. Background

    Background - CRIS Registration Number, Unique Protocol ID, Public/Brief Title, Scientific Title, Acronym, MFDS Regulated Study, IND/IDE Protocol, Registered at Other Registry, Name of Registry/Registration Number
    CRIS
    Registration Number
    KCT0002541
    Unique Protocol ID ED16199
    Public/Brief Title Study for diagnostic accuracy of dual capsule endoscopy
    Scientific Title Prospective study for comparison of detetion rate for AOV between dual capsule endoscopy and single capsuel endoscopy
    Acronym
    MFDS Regulated Study No
    IND/IDE Protocol No
    Registered at Other Registry No
    Healthcare Benefit Approval Status
  • 2. Institutional Review Board / Ethics Committee

    Institutional Review Board Information
    Board Approval Status Submitted approval
    Board Approval Number ED16199
    Approval Date 2016-09-12
    Institutional Review Board Name Korea University Anam Hospital Institutional review board
    Institutional Review Board Address
    Institutional Review Board Telephone
    Data Monitoring Committee
  • 3. Contact Details

    Contact Details Information - Contact Person for Principal Investigator / Scientific Queries, Contact Person for Public Queries, Contact Person for Updating Information의 Name, Title, Email, Telephone, Cellular Phone, Affiliation, Address
    Contact Person for Principal Investigator / Scientific Queries
    Name Seung Han Kim
    Title M.D., Ph.D.
    Telephone +82-2-920-6555
    Affiliation Korea University Anam Hospital
    Address Anam-dong 5 ga, Seongbuk-gu, Seoul 02841, Republic of Korea.
    Contact Person for Public Queries
    Name Seung Han Kim
    Title M.D., Ph.D.
    Telephone +82-2-920-6555
    Affiliation Korea University Anam Hospital
    Address Anam-dong 5 ga, Seongbuk-gu, Seoul 02841, Republic of Korea.
    Contact Person for Updating Information
    Name Seung Han Kim
    Title M.D., Ph.D.
    Telephone +82-2-920-6555
    Affiliation Korea University Anam Hospital
    Address Anam-dong 5 ga, Seongbuk-gu, Seoul 02841, Republic of Korea.
  • 4. Status

    Status Information - Study Site, Overall Recruitment Status, Date of First Enrollment, Status of First Enrollment, Target Number of Participant, Primary Completion Date, Recruitment Status by Participating Study Site, Name of Study Site, Recruitment Status, Date of First Enrollment, Status of First Enrollemnt
    Study Site Single
    Overall Recruitment Status Recruiting
    Date of First Enrollment 2017-07-18 Actual
    Target Number of Participant 50
    Primary Completion Date
    Study Completion Date
    Recruitment Status by Participating Study Site 1
    Name of Study Korea University
    Recruitment Status Recruiting
    Date of First Enrollment 2017-07-18 ,
  • 5. Source of Monetary / Material Support

    Source of Monetary / Material Support Information - Organization Name, Organization Type, Project ID
    1. Source of Monetary/Material Support
    Organization Name Ministry of Trade, Industry & Energy
    Organization Type Government
    Project ID
  • 6. Sponsor Organization

    Sponsor Organization Information - Organization Name, Organization Type
    1. Sponsor Organization
    Organization Name Korea University
    Organization Type University
  • 7. Study Summary

    Study Summary Information
    Lay Summary
    Capsule endoscopy (CE) is a noninvasive option for investigating the small bowel disorder. However, several studies have reported that the visualization of the small intestine with CE is suboptimal. In the present study, we aimed to evaluate the diagnostic ability of dual CE examination.
  • 8. Study Design

    Study Design Information - Study Type, Study Purpose, Phase, Intervention Model, Blinding/Masking, Blinded Subject, Allocation, Intervention Type, Intervention Description, Number of Arms, Arm Label, Target Number of Participant, Arm Type, Arm Description
    Study Type Interventional Study
    Study Purpose
    Diagnosis
    Phase Not applicable
    Intervention Model Parallel  
    Blinding/Masking Double
    Blinded Subject Subject, Investigator
    Allocation RCT
    Intervention Type Medical Device  
    Intervention Description
    Comparative Analysis of Single and Double Doses of Capsule Endoscopy
    Number of Arms 2
    Arm 1

    Arm Label

    Comparative Analysis of Double Doses of Capsule Endoscopy

    Target Number of Participant

    25

    Arm Type

    Experimental

    Arm Description

    Two capsule endoscopes were administered simultaneously to determine the lesion detection rate
    Arm 2

    Arm Label

    Comparative Analysis of single Dose of Capsule Endoscopy

    Target Number of Participant

    25

    Arm Type

    Active comparator

    Arm Description

    one capsule endoscope were administered simultaneously to determine the lesion detection rate
  • 9. Subject Eligibility

    Subject Eligibility Information
    Condition(s)/Problem(s) * (R00-R99)Symptoms, signs and abnormal clinical and laboratory findings, NEC 
       (R10.49)Unspecified abdominal pain 
    Rare Disease No
    Inclusion Criteria

    Gender

    Both

    Age

    18Year~80Year

    Description

    OGIB, chronic diarrhea, and chronic abdominal pain 
    Exclusion Criteria
    small bowel stenosis, swallowing difficulties, severe advanced respiratory disease, or cardiovascular or neuropsychiatric disease. Pregnant patients and those with implantable electronic devices were also excluded. 
    Healthy Volunteers
  • 10. Outcome Measure(s)

    Outcome Measure(s) Information - Type of Primary Outcome, Primary Outcome, Outcome, Timepoint, Secondary Outcome, Outcome, Timepoint
    Type of Primary Outcome /Safety/Efficacy
    Primary Outcome(s) 1
    Outcome
    detection rate of small bowel lesion 
    Timepoint
    after 24hours  
    Secondary Outcome(s) 1
    Outcome
    adverse events
    Timepoint
    after 24hours 
  • 11. Study Results and Publication

    Study Results and Publication Information - Result Registered, Final Enrollment Number, Number of Publication, Publications, Results Upload, Date of Posting Results, Protocol URL or File Upload, Brief Summary
    Result Registered
  • 12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)

    Sharing of Study Data Information - Sharing Statement, Time of Sharing, Way of Sharing
    Sharing Statement Not provided at time of Registration
화면 최상단으로 이동

TOP

BOTTOM

화면 최하단으로 이동